COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration COEPTIS Completes $10 Million Series A Preferred Financing...
PR Newswire·7mo ago
More News
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation PR...
PR Newswire·8mo ago
Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation...
PR Newswire·8mo ago
Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform PR Newswire...
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies Coeptis Therapeutics Makes Bold Strides in...
PR Newswire·9mo ago
Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development Coeptis Therapeutics Announces...
PR Newswire·10mo ago
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic...
PR Newswire·11mo ago
Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy
Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy Coeptis Therapeutics' Chief Scientific and Medical...